Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 3/2005

01-06-2005

Hepatofugal portal flow due to acute cellular rejection

Authors: Y. Kyoden, Y. Sugawara, Y. Matsui, Y. Kishi, N. Akamatsu, M. Makuuchi

Published in: Abdominal Radiology | Issue 3/2005

Login to get access

Abstract

We describe a case of living donor liver transplantation with hepatofugal portal flow caused by acute cellular rejection. The reversed portal flow was corrected by splenectomy and ligation of the residual collateral veins. Hepatofugal flow causes ischemic damage to the graft, which does not normalize spontaneously. In this particular case, meticulous Doppler ultrasound examination and prompt response to reversed portal flow salvaged the graft.
Literature
1.
Takayama, T, Makuuchi, M, Kubota, K,  et al. 2000Living-related transplantation of left liver plus caudate lobeJ Am Coll Surg190635638CrossRefPubMed
2.
Urata, K, Kawasaki, S, Matsunami, H,  et al. 1995Calculation of child and adult standard liver volume for liver transplantationHepatology2113171321CrossRefPubMed
3.
Sugawara, Y, Makuuchi, M, Kaneko, J,  et al. 2002Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantationClin Transpl16102106CrossRef
4.
Handengue, A, Lebrec, D, Moreau, R,  et al. 1993Persistence of systemic and splanchnic hyperkinetic circulation in liver transplantation patientsHepatology17175178CrossRefPubMed
5.
DeCarlis, L, Favero, E, Rondinara, G,  et al. 1992The role of spontaneous portosystemic shunts in the course of orthotopic liver transplantationTranspl Int5914CrossRefPubMed
6.
Sugimoto, H, Kaneko, T, Marui, Y,  et al. 2001Reversal of portal flow after acute rejection in living-donor liver transplantationJ Hepatobiliary Pancreat Surg8573576CrossRefPubMed
7.
Cescon, M, Sugawara, Y, Takayama, T,  et al. 2001Role of splenectomy in living donor transplantation for adultsHepatogastroenterology49721723
8.
Cescon, M, Sugawara, Y, Kaneko, J,  et al. 2001Restoration of portal vein flow by splenorenal shunt ligation and splenectomy after living-related liver transplantationHepatogastroenterology4814531454PubMed
9.
Reding, R, Gras, J, Sokal, E,  et al. 2003Steroid-free liver transplantation in childrenLancet36220682070CrossRefPubMed
10.
Aw, MM, Taylor, RM, Verma, A,  et al. 2003Basiliximab for the treatment of steroid-resistant rejection in pediatric liver transplanted recipients: a preliminary experienceTransplantation75796799CrossRefPubMed
Metadata
Title
Hepatofugal portal flow due to acute cellular rejection
Authors
Y. Kyoden
Y. Sugawara
Y. Matsui
Y. Kishi
N. Akamatsu
M. Makuuchi
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 3/2005
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-004-0269-1

Other articles of this Issue 3/2005

Abdominal Radiology 3/2005 Go to the issue

OriginalPaper

Colon stenosis caused by old portal vein thrombosis

OriginalPaper

Abstracts of selected papers from the current literature

Invited Review

Malignant biliary obstruction: value of imaging findings

OriginalPaper

Diffuse esophageal stricture secondary to esophageal lichen planus

OriginalPaper

Magnetic resonance T1 gradient-echo imaging in hepatolithiasis

Invited update

Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits